From: Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer
Overall survival | Progression-free survival | |||||
---|---|---|---|---|---|---|
Hazard ratio | 95% Confidence interval | P value | Hazard ratio | 95% Confidence interval | P value | |
Age | 0.942 | 0.628-2.093 | 0.272 | 0.872 | 0.389-1.845 | 0.356 |
FIGO stage | 3.893 | 1.267-9.273 | 0.031 | 4.342 | 1.925-10.287 | 0.009 |
Histology | 1.272 | 0.287-3.532 | 0.783 | 1.372 | 0.228-2.091 | 0.691 |
Residual tumor size | 2.382 | 0.871-6.281 | 0.086 | 2.192 | 0.754-3.002 | 0.072 |
Grade | 3.091 | 2.004-8.921 | 0.021 | 3.971 | 2.716-9.021 | 0.012 |
Lymph node metastases | 1.872 | 1.022-9.655 | 0.031 | 3.911 | 2.241-12.891 | 0.009 |
Serum CA125 | 3.297 | 0.652-7.271 | 0.051 | 2.467 | 0.811-6.188 | 0.068 |
MiR-22 expression level | 2.552 | 1.961-9.763 | 0.007 | 2.341 | 2.021-11.672 | 0.005 |